Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yongfeng Chen

Showing results (131-140 of 152) with videos related to

Pageof 16
Sort By:
Heliyon|September 28, 2023
Different gene alterations in patients with non-small-cell lung cancer between the eastern and southern ChinaChengdong Liu, Kangbao Li, Yi Sui, et al.
Asian Journal of Pharmaceutical Sciences|April 8, 2024
Targeted anti-cancer therapy: Co-delivery of VEGF siRNA and Phenethyl isothiocyanate (PEITC) via cRGD-modified lipid nanoparticles for enhanced anti-angiogenic efficacyBao Li, Haoran Niu, Xiaoyun Zhao, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 22, 2025
Biomimetic Nanoplatform for Targeted Rheumatoid Arthritis Therapy: Modulating Macrophage Niches Through Self-Sustaining Positive Feedback-Driven Drug Release MechanismsHuichao Xie, Xiaoyu Huang, Bao Li, et al.
The Journal of International Medical Research|June 22, 2017
Simultaneous ABO-incompatible living-donor liver transplantation and splenectomy without plasma exchange in China: Two case reportsGuoyong Chen, Janjun Sun, Sidong Wei, et al.
Photodiagnosis and Photodynamic Therapy|December 8, 2025
Comparative efficacy of photodynamic therapy versus conventional therapies for actinic keratosis: A systematic review and meta-analysisAla'a Suwait Deeb Al Suwait, Rongyi Chen, Ziad Fayez Mohammad Alkouz, et al.
Frontiers in Immunology|June 24, 2026
First-line serplulimab plus chemotherapy versus chemotherapy alone in small-cell lung cancer patients with brain metastases: a multicenter, prospective cohort studyWan Zhang, Xiaojun Yang, Hualin Chen, et al.
Acta Pharmaceutica Sinica. B|July 14, 2025
Tranexamic acid-fatty alcohol polyoxyethylene ether conjugation/PVA foam for venous sclerotherapy <i>via</i> vascular damage and inhibiting plasmin systemJizhuang Ma, Keda Zhang, Wenhan Li, et al.
Materials Today. Bio|December 19, 2024
Enhanced sclerotherapy for vascular malformations: A dual-mechanism approach using in-situ forming PATDs gelJizhuang Ma, Wenhan Li, Yu Ding, et al.
Discover Oncology|May 12, 2026
Pan-cancer investigation identifies ARL4A as a prospective therapeutic indicator for thyroid cancerYingli Men, Jizhi Zhao, Ruiting Feng, et al.
Materials Today. Bio|February 3, 2025
Corrigendum to 'Enhanced sclerotherapy for vascular malformations: A dual-mechanism approach using in-situ forming PATDs gel' [Mater. Today Bio 29 (2024) 101376]Jizhuang Ma, Wenhan Li, Yu Ding, et al.
Pageof 16

Showing results (131-140 of 152) with videos related to

Sort By:
Pageof 16
Heliyon|September 28, 2023
Different gene alterations in patients with non-small-cell lung cancer between the eastern and southern ChinaChengdong Liu, Kangbao Li, Yi Sui, et al.
Asian Journal of Pharmaceutical Sciences|April 8, 2024
Targeted anti-cancer therapy: Co-delivery of VEGF siRNA and Phenethyl isothiocyanate (PEITC) via cRGD-modified lipid nanoparticles for enhanced anti-angiogenic efficacyBao Li, Haoran Niu, Xiaoyun Zhao, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 22, 2025
Biomimetic Nanoplatform for Targeted Rheumatoid Arthritis Therapy: Modulating Macrophage Niches Through Self-Sustaining Positive Feedback-Driven Drug Release MechanismsHuichao Xie, Xiaoyu Huang, Bao Li, et al.
The Journal of International Medical Research|June 22, 2017
Simultaneous ABO-incompatible living-donor liver transplantation and splenectomy without plasma exchange in China: Two case reportsGuoyong Chen, Janjun Sun, Sidong Wei, et al.
Photodiagnosis and Photodynamic Therapy|December 8, 2025
Comparative efficacy of photodynamic therapy versus conventional therapies for actinic keratosis: A systematic review and meta-analysisAla'a Suwait Deeb Al Suwait, Rongyi Chen, Ziad Fayez Mohammad Alkouz, et al.
Frontiers in Immunology|June 24, 2026
First-line serplulimab plus chemotherapy versus chemotherapy alone in small-cell lung cancer patients with brain metastases: a multicenter, prospective cohort studyWan Zhang, Xiaojun Yang, Hualin Chen, et al.
Acta Pharmaceutica Sinica. B|July 14, 2025
Tranexamic acid-fatty alcohol polyoxyethylene ether conjugation/PVA foam for venous sclerotherapy <i>via</i> vascular damage and inhibiting plasmin systemJizhuang Ma, Keda Zhang, Wenhan Li, et al.
Materials Today. Bio|December 19, 2024
Enhanced sclerotherapy for vascular malformations: A dual-mechanism approach using in-situ forming PATDs gelJizhuang Ma, Wenhan Li, Yu Ding, et al.
Discover Oncology|May 12, 2026
Pan-cancer investigation identifies ARL4A as a prospective therapeutic indicator for thyroid cancerYingli Men, Jizhi Zhao, Ruiting Feng, et al.
Materials Today. Bio|February 3, 2025
Corrigendum to 'Enhanced sclerotherapy for vascular malformations: A dual-mechanism approach using in-situ forming PATDs gel' [Mater. Today Bio 29 (2024) 101376]Jizhuang Ma, Wenhan Li, Yu Ding, et al.
Pageof 16